These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 3095102
21. Tyrosinase activity in primary cell culture of amelanotic melanoma cells. Słomiński A, Scisłowski PW, Bomirski A. Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964 [Abstract] [Full Text] [Related]
27. [Structural factors and the DOPA oxidase activity of membrane-bound tyrosinase]. Shtol'ko VN, Kol'tover VK, Il'in AV, Vasil'eva LS, Bogdanov GN. Dokl Akad Nauk SSSR; 1979 Nov; 244(4):1009-12. PubMed ID: 104854 [No Abstract] [Full Text] [Related]
28. Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C. Mahalingam H, Vaughn J, Novotny J, Gruber JR, Niles RM. J Cell Physiol; 1996 Sep; 168(3):549-58. PubMed ID: 8816909 [Abstract] [Full Text] [Related]
29. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent. Abdel Malek ZA, Kreutzfeld KL, Hadley ME, Bregman MD, Hruby VJ, Meyskens FL. In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484 [Abstract] [Full Text] [Related]
30. Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line. DiSorbo DM, Harris NA, Nathanson L. Cancer Res; 1984 May; 44(5):1752-5. PubMed ID: 6424929 [Abstract] [Full Text] [Related]
31. Effect of thymidine analogs on tyrosinase activity and mRNA accumulation in mouse melanoma cells. Kidson SH, De Haan JB. Exp Cell Res; 1990 May; 188(1):36-41. PubMed ID: 2139417 [Abstract] [Full Text] [Related]
32. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells. Imokawa G, Mishima Y. Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485 [Abstract] [Full Text] [Related]
33. Inhibitory effect of danazol on melanogenesis in mouse B16 melanoma cells. Chang TS, Lin JJ. Arch Pharm Res; 2010 Dec; 33(12):1959-65. PubMed ID: 21191761 [Abstract] [Full Text] [Related]
34. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors. Imokawa G, Mishima Y. J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920 [Abstract] [Full Text] [Related]
35. The involvement of histidine at the active site of Harding-Passey mouse melanoma tyrosinase. Martínez JH, Solano F, García-Borrón JC, Iborra JL, Lozano JA. Biochem Int; 1985 Nov; 11(5):729-38. PubMed ID: 3937527 [Abstract] [Full Text] [Related]
36. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma. Blagoeva PM. Neoplasma; 1977 Nov; 24(3):291-4. PubMed ID: 408715 [Abstract] [Full Text] [Related]
37. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase. Iwata K, Takeuchi T. J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850 [Abstract] [Full Text] [Related]
38. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma. Sato K, Toriyama M. J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771 [Abstract] [Full Text] [Related]
39. [Tyrosinase and dopa oxidase in amelanotic melanoma in man]. Chicewicz M, Roczniak E. Wiad Lek; 1977 Aug 01; 30(15):1187-91. PubMed ID: 410164 [No Abstract] [Full Text] [Related]